- Home
- PSMT vs XENE Comparison
PSMT vs XENE Comparison
Compare PSMT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSMT | XENE |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.2B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PSMT | XENE |
|---|---|---|
| Price | $169.23 | $54.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $68.55 |
| AVG Volume (30 Days) | 189.7K | ★ 998.9K |
| Earning Date | 04-08-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 5.47 | N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $4,066,093,000.00 | $311,000.00 |
| Revenue This Year | $12.29 | N/A |
| Revenue Next Year | $10.70 | $2,496.48 |
| P/E Ratio | $58.86 | ★ N/A |
| Revenue Growth | ★ 12.33 | N/A |
| 52 Week Low | $99.98 | $28.97 |
| 52 Week High | $171.53 | $62.91 |
Technical Indicators
Market Signals| Indicator | PSMT | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 46.83 |
| Support Level | $153.14 | $52.90 |
| Resistance Level | N/A | $59.43 |
| Average True Range (ATR) | 4.39 | 1.48 |
| MACD | 0.97 | -0.09 |
| Stochastic Oscillator | 88.66 | 39.93 |
Price Performance
Historical ComparisonAbout PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.